These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16681048

  • 1. Vogt-Koyanagi-Harada disease in Thai patients.
    Tesavibul N, Sansanayuth W.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S26-30. PubMed ID: 16681048
    [Abstract] [Full Text] [Related]

  • 2. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD, Rathinam SR, Cunningham ET.
    Retina; 2010 Nov; 30(7):1113-21. PubMed ID: 20168275
    [Abstract] [Full Text] [Related]

  • 3. Vogt-Koyanagi-Harada disease: clinical outcomes.
    Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA.
    Am J Ophthalmol; 2005 Oct; 140(4):674-8. PubMed ID: 16226518
    [Abstract] [Full Text] [Related]

  • 4. [Vogt-Koyanagi-Harada syndrome. Epidemiological, clinical and disease progression aspects. Twenty cases].
    Boutimzine N, Laghmari A, Ouazzani I, Ibrahimy W, Mohcine Z.
    J Fr Ophtalmol; 1998 Dec; 21(10):746-54. PubMed ID: 10052048
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
    Chee SP, Jap A, Bacsal K.
    Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
    Paredes I, Ahmed M, Foster CS.
    Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
    [Abstract] [Full Text] [Related]

  • 7. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
    Berker N, Ozdamar Y, Soykan E, Ozdal P, Ozkan SS.
    Ocul Immunol Inflamm; 2007 Apr; 15(4):351-7. PubMed ID: 17763135
    [Abstract] [Full Text] [Related]

  • 8. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M, Ganesh SK, Biswas J.
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [Abstract] [Full Text] [Related]

  • 9. Revised diagnostic criteria for vogt-koyanagi-harada disease: considerations on the different disease categories.
    da Silva FT, Damico FM, Marin ML, Goldberg AC, Hirata CE, Takiuti PH, Olivalves E, Yamamoto JH.
    Am J Ophthalmol; 2009 Feb; 147(2):339-345.e5. PubMed ID: 18992868
    [Abstract] [Full Text] [Related]

  • 10. Vogt-Koyanagi-Harada disease in children.
    Abu El-Asrar AM, Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D.
    Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
    [Abstract] [Full Text] [Related]

  • 11. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N, Morisod L, Herbort CP.
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [Abstract] [Full Text] [Related]

  • 12. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
    Fang W, Zhou H, Yang P, Huang X, Wang L, Kijlstra A.
    Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
    [Abstract] [Full Text] [Related]

  • 13. [Vogt-Koyanagi-Harada disease].
    Kjeka O, Krohn J.
    Tidsskr Nor Laegeforen; 2005 Aug 25; 125(16):2195-7. PubMed ID: 16138134
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, Lehoang P, Lemaitre C, Okada AA, Pivetti-Pezzi P, Secchi A, See RF, Tabbara KF, Usui M, Rao NA.
    Am J Ophthalmol; 2006 Jul 25; 142(1):119-24. PubMed ID: 16815259
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P, Wang H, Zhou H, Zhong H, Li F, Huang X, Zhong H, Fu T.
    Zhonghua Yan Ke Za Zhi; 2002 Apr 25; 38(4):196-9. PubMed ID: 12133384
    [Abstract] [Full Text] [Related]

  • 16. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
    Chee SP, Jap A.
    Br J Ophthalmol; 2013 Feb 25; 97(2):130-3. PubMed ID: 23212203
    [Abstract] [Full Text] [Related]

  • 17. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P, Sun M.
    Cornea; 2011 Dec 25; 30(12):1336-40. PubMed ID: 21934492
    [Abstract] [Full Text] [Related]

  • 18. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
    Lai TY, Chan RP, Chan CK, Lam DS.
    Eye (Lond); 2009 Mar 25; 23(3):543-8. PubMed ID: 18369377
    [Abstract] [Full Text] [Related]

  • 19. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
    Errera MH, Fardeau C, Cohen D, Navarro A, Gaudric A, Bodaghi B, Westcott M, LeHoang P.
    Acta Ophthalmol; 2011 Jun 25; 89(4):e357-66. PubMed ID: 21251241
    [Abstract] [Full Text] [Related]

  • 20. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
    Nazari H, Rao NA.
    Br J Ophthalmol; 2012 Nov 25; 96(11):1410-4. PubMed ID: 22942161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.